Tesla (TSLA) completes $2.7B funding round as BMW pledges more EV competition
Tesla (NASDAQ:TSLA) announced on Wednesday that it had closed its $2.7 billion offering of stock and convertible notes. The electric car maker also noted that it had oversubscribed its funding round, giving the company ample cash as it ramps up Model 3 production and prepares for other high-profile projects like the rollout of the Model Y and the Tesla Semi.
Overall, Tesla sold about $860 million in TSLA stock and $1.84 billion in debt, after the underwriters exercised their option of buying 15% in each offering. Tesla’s filings indicate that its recently-completed funding round was underwritten by Goldman Sachs, Bank of America, Societe Generale, Citigroup, Deutsche Bank, Morgan Stanley, Credit Suisse, and Wells Fargo.
The completion of Tesla’s latest funding round came just a day after Elon Musk confirmed that he purchased a total of $25 million worth of TSLA stock for $243.00 per share. Musk’s purchase involved 102,880 shares, bringing his total of Tesla stock to 33,927,560 shares, or around 19.5% of the company.
As Tesla prepares to ramp its activities with its new funding, veteran automaker BMW has expressed its intention to put pressure on the electric vehicle market. BMW had a tough first quarter, reporting earnings of $667 million, or down 75% year over year. Despite this, BMW’s management reiterated the company’s commitment to electrification.
BMW noted that the company currently holds 11% of the US luxury market, which is double Tesla’s share, thanks to its lineup of internal combustion-vehicles like the BMW 5-Series (which competes with the Model S), the X5 (which is in the same segment as the Model X), the 3-Series (which competes with the Model 3), and a variety of other models. Tesla only offers three vehicles that compete on the US luxury market, though the electric car maker has noted that the Model S outsells its equivalent BMW competitor by 2-3 times.
While BMW commands a larger portion of the US luxury market than Tesla, the German automaker lags behind the Silicon Valley company in terms of EV sales. BMW delivered more than 27,000 electric cars so far in 2019, while Tesla delivered more than 63,000 in the first quarter alone. Nevertheless, BMW notes that its electric vehicle figures will increase as it initiates its “25 by 25” program, which is aimed at rolling out 25 electric and electrified vehicles by 2025.
As the electric vehicle market enters another stage with a freshly-funded Tesla, BMW Chairman Harald Kruger expressed his confidence that the German automaker will remain competitive. “In Europe, our percentage of electrified vehicles delivered is three times the industry average. In 2018, we were the market leader for electrification in both Europe and Germany—not just in the premium segment, but in the market as a whole. We plan to maintain a leading position going forward—both in Europe and worldwide,” he said.
As of writing, Tesla stock is trading +0.87% at $249.22 per share.
Disclosure: I have no ownership in shares of TSLA and have no plans to initiate any positions within 72 hours.
The post Tesla (TSLA) completes $2.7B funding round as BMW pledges more EV competition appeared first on TESLARATI.
Source: https://www.teslarati.com/tesla-tsla-completes-2-billion-funding-round-bmw-25-evs-2015/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.